10-K/A: Syra Health Corp. Files Amendment to Annual Report

Syra Health Corp. files Amendment No. 1 to its Form 10-K for the fiscal year ended December 31, 2025, to include previously omitted Part III information.

Summary

• Syra Health Corp. is filing an amendment (Amendment No. 1) to its Annual Report on Form 10-K for the fiscal year ended December 31, 2025.
• This amendment is being filed solely to include information required by Items 10 through 14 of Part III, which was initially omitted.
• The company is filing this amendment because it will not file a definitive proxy statement containing this information within the required 120-day period after the fiscal year-end.
• The amendment restates Items 10 through 14 of the original 10-K and includes new certifications from the CEO and CFO as required by Section 302 of the Sarbanes-Oxley Act.
• The filing does not include financial statements and therefore omits certain certification paragraphs.
• The original 10-K remains effective as of its original filing date, and this amendment does not update disclosures for events occurring after that date.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this filing as neutral, as it is a procedural amendment to correct an omission rather than a report on new financial performance or strategic developments.

Negatives

• The company is filing an amendment because it will not meet the deadline for filing its definitive proxy statement, indicating a potential administrative or procedural oversight.
• The need to file an amendment to include Part III information suggests a delay in providing complete disclosures, which could be perceived negatively by investors.

Future Outlook

This filing is an amendment to a previous annual report and does not contain new forward-looking statements or guidance. It primarily addresses the inclusion of Part III information.

Management Comments

• Gregory R. Alexander, CEO, certifies that the report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading.
• Priya Prasad, CFO, certifies that the report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading.

Industry Context

StockSavvy.ai notes that the filing of an amendment to an annual report, particularly to include Part III information, is a procedural step to ensure compliance with SEC regulations. While not indicative of operational performance, it highlights the importance of timely and complete disclosure in the healthcare technology sector.

Corporate Governance

Stakeholder Impact

• Shareholders: The amendment provides previously omitted information, enhancing transparency regarding corporate governance, executive compensation, and security ownership.

Next Steps

• The company will need to ensure future filings, including proxy statements, are submitted within the required timeframes to avoid similar amendments.

Key Dates

Keywords

Syra Health Corp, 10-K Amendment, SEC Filing, Annual Report, Corporate Governance, Executive Compensation, Director Information, Related Party Transactions, Sarbanes-Oxley Act